黑料网

Biography

Suleiman Al-Obeid, MD, PhD, was completed my residency in Internal Medicine at Damascus University School of Medicine in Syria and Paris 6 university in France. Dr al-Obeid did his Clinical and microbiological research on the mechanism of bacterial resistance in the molecular Research laboratory at Paris 6 university Department of Microbiology, School of Medicine. Dr al-Obeid was Assistant Professor at Damascus University School of Medicine. He is a member in the French & European society of microbiology. Dr. al-Obeid has several scientific papers and projects either presented or published. He is an internationally recognized expert in many areas of advanced medicine including Internal Medicine, infectious Diseases & Clinical Microbiologic Research. He is a regularly sought after and requested lecturer at the majority of major medical schools, health systems, and National Medical Symposiums throughout the United States and Europe. Dr. al-Obeid is reviewer for Several International Journal of Medicine in clinical microbiology and infection control. Recent publications include a paper on the resistance of Heterogeneous vancomycin resistance staphylococcus Aureus & another on the epidemiology of extensive drug resistant Acinetobacter baumannii. Dr. al-Obeid is recognized by his peers as a Scientific and Medical expert that integrates new protocol in the treatment of multi-drug resistant gram negative bacteria like Acinetobacter baumannii highly resistant to the most of antibiotics especially patients suffering from acute and chronic ventilator associated pneumoniae VAP and bacteremia in the ICU. Actually Dr. al-Obeid is head of clinical microbiology department, member of the infectious disease unite and the Co-chairman of infection control department at the Security Forces Hospital in Riyadh Saudi Arabia. Dr. al-Obeid is an active member in the club on microbiology and infectious disease in Riyadh. Dr Obeid has honored several time at the security forces hospital for his valuable work. Dr Obeid presents his latest research at the 54th interscience conference on antimicrobial agent and chemotherapy ICAAC 2014 a Washington DC on the fifth of September 2014.

Research Interest

Microbiology and Infection Diseases
Molecular Bacteriology
Clinical Bacteriology-Virology